These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 2972670)
1. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. Watanakunakorn C J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670 [TBL] [Abstract][Full Text] [Related]
2. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin. Watanakunakorn C J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602 [TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units]. Bourgeois F; Bingen E; Lambert-Zechovsky N Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278 [TBL] [Abstract][Full Text] [Related]
4. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Goldstein FW; Coutrot A; Sieffer A; Acar JF Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780 [TBL] [Abstract][Full Text] [Related]
5. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903 [TBL] [Abstract][Full Text] [Related]
6. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens]. Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426 [TBL] [Abstract][Full Text] [Related]
8. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. Del Bene VE; John JF; Twitty JA; Lewis JW J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491 [No Abstract] [Full Text] [Related]
9. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098 [TBL] [Abstract][Full Text] [Related]
11. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. Felmingham D; Brown DF; Soussy CJ Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397 [TBL] [Abstract][Full Text] [Related]
13. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit. Moore EP; Speller DC J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810 [TBL] [Abstract][Full Text] [Related]
14. Comparative activity of glycopeptide antibiotics against coagulase-negative staphylococci embedded in fibrin clots. Cunningham R; Cheesbrough J J Antimicrob Chemother; 1992 Sep; 30(3):321-6. PubMed ID: 1452497 [TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Sieradzki K; Villari P; Tomasz A Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268 [TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics]. Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772 [TBL] [Abstract][Full Text] [Related]
17. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Ahlstrand E; Svensson K; Persson L; Tidefelt U; Söderquist B Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1349-54. PubMed ID: 21744039 [TBL] [Abstract][Full Text] [Related]
18. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)]. Kayaokay Y; Hasçelik G; Gür D; Akalin E Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050 [TBL] [Abstract][Full Text] [Related]
19. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci. Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294 [TBL] [Abstract][Full Text] [Related]
20. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection. Aubert G; Passot S; Lucht F; Dorche G J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112 [No Abstract] [Full Text] [Related] [Next] [New Search]